Pomerantz Appointed Lead Counsel in Provention Bio Securities Litigation

On November 17, 2021, U.S. District Judge Michael A. Shipp of the District of New Jersey appointed Pomerantz LLP as Lead Counsel on behalf of George L. Jordan, Jr., Lead Plaintiff in Paxton v. Provention Bio, Inc., 21-cv-11613 (D.N.J.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Provention Bio, Inc. had made false and misleading statements regarding the sufficiency of testing data and approval prospects for its lead product candidate for the treatment of type one diabetes Provention is a clinical stage biopharmaceutical company that develops and…